Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results.

Related Articles Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results. J Thorac Cardiovasc Surg. 2017 03;153(3):669-674 Authors: Perri G, Filippelli S, Adorisio R, Iacobelli R, Iodice F, Testa G, Paglietti MG, D’Amario D, Massetti M, Amodeo A Abstract OBJECTIVE: We report our experience with the use of a left ventricular assist device (LVAD) as destination therapy (DT) for the management of patients with cardiac end-stage dystrophinopathies. METHODS: From February 2011 to February 2016, 7 patients with dystrophinopathies and dilated cardiomyopathy (DCM) were treated with LVADs at our institution. Median age at surgery was 16.5 years (range,…
Origen: Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results. – PubMed